AprilBio Co.,Ltd.
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
397030 | KO
Overview
Corporate Details
- ISIN(s):
- KR7397030008
- LEI:
- Country:
- South Korea
- Address:
- 강원도 춘천시 강원대학길 1 의생명과학대학 B동 602호, 춘천시
- Website:
- http://www.aprilbio.com/en/
Description
AprilBio is a biotechnology company that develops innovative biologic drugs, including therapeutic antibodies and recombinant proteins. The company's core is its proprietary SAFA (anti-Serum Albumin Fab-Associated) platform technology, which utilizes an albumin-binding antibody fragment to create long-acting therapeutics. This platform is designed to enhance the efficacy, safety, and plasma half-life of drug candidates while minimizing adverse effects. AprilBio's research and development pipeline focuses on addressing unmet medical needs in therapeutic areas such as autoimmune diseases, oncology, and other inflammatory and rare diseases. The company advances new drug candidates through early clinical development stages for potential technology transfer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-11-27 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 66.0 KB | ||
| 2024-11-21 00:00 |
전환사채(해외전환사채포함)발행후만기전사채취득 (제1회차)
|
Korean | 11.2 KB | ||
| 2024-11-19 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 74.6 KB | ||
| 2024-11-14 00:00 |
분기보고서 (2024.09)
|
Korean | 761.0 KB | ||
| 2024-11-08 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2024-10-21 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.4 KB | ||
| 2024-10-02 00:00 |
전환청구권행사 (제1회차)
|
Korean | 10.9 KB | ||
| 2024-09-11 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 107.4 KB | ||
| 2024-09-11 00:00 |
주식매수선택권부여에관한신고
|
Korean | 16.0 KB | ||
| 2024-09-10 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2024-08-12 00:00 |
반기보고서 (2024.06)
|
Korean | 1.0 MB | ||
| 2024-08-02 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 76.4 KB | ||
| 2024-07-19 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.7 KB | ||
| 2024-07-19 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 20.9 KB | ||
| 2024-06-20 00:00 |
투자판단관련주요경영사항 (자가염증질환 치료제 APB-R3 기술이전 계약체결)
|
Korean | 14.7 KB |
Automate Your Workflow. Get a real-time feed of all AprilBio Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AprilBio Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AprilBio Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
